In adults, Henoch-Schonlein Purpura may present more insidiously with potential myocardial involvement.
About
- Henoch-Schonlein Purpura (HSP) is a systemic small vessel leukocytoclastic vasculitis, often presenting with a palpable purpuric rash due to bleeding into the dermis.
- This condition affects the skin, joints, kidneys, and gastrointestinal (GI) tract, primarily involving small blood vessels.
Aetiology
- IgA immune complex deposition in small blood vessels, particularly venules, capillaries, and arterioles.
- Often associated with preceding infections such as Group A Streptococci and Mycoplasma.
Clinical Presentation
- Typical purpuric rash primarily on lower limbs and buttocks, sparing the trunk and face.
- Most commonly seen in children but can occur at any age.
- May present with abdominal pain, PR bleeding, or complications like intussusception in severe cases.
Investigations
- Blood Tests: FBC, U&E, and clotting profiles, particularly if non-classical purpura or if the patient has systemic symptoms or renal involvement.
- Urinalysis: Check for haematuria and proteinuria; significant proteinuria is marked as 2+ or higher.
- Throat Swab & ASOT: Check for possible infectious triggers like Group A Streptococcus.
Renal Disease Findings
- Normal complement C3 and C4 levels, distinguishing it from post-streptococcal glomerulonephritis.
- Skin Biopsy: Immunofluorescence may reveal leukocytoclastic vasculitis with IgA and C3 deposits.
- Renal Biopsy: In cases of significant renal involvement, biopsy typically shows a focal segmental proliferative glomerulonephritis with mesangial IgA deposition, similar to IgA nephropathy.
Management
- Generally, HSP has a good prognosis, with most cases resolving conservatively with supportive care.
- In mild, classical cases, only urinalysis may be needed, with escalation in management if symptoms worsen or with significant joint involvement, malaise, proteinuria, or haematuria.
- For ongoing renal monitoring, patients or parents can perform daily urine dipsticks for several weeks. Escalation is needed if signs of renal disease appear.
- In rare cases leading to rapidly progressive glomerulonephritis, steroids or immunosuppressants may be indicated. Approximately 1-5% may progress to end-stage renal failure.